Name | Number of supported studies | Average coverage | |
---|---|---|---|
basal cell | 5 studies | 18% ± 4% | |
conventional dendritic cell | 3 studies | 19% ± 3% | |
dendritic cell | 3 studies | 35% ± 2% |
Insufficient scRNA-seq data for expression of CYP2S1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
stomach | 86% | 3666.88 | 309 / 359 | 95% | 258.11 | 272 / 286 |
intestine | 78% | 1013.39 | 752 / 966 | 96% | 230.31 | 507 / 527 |
lung | 99% | 652.05 | 575 / 578 | 69% | 117.77 | 798 / 1155 |
esophagus | 62% | 637.83 | 900 / 1445 | 90% | 211.28 | 165 / 183 |
bladder | 71% | 311.67 | 15 / 21 | 44% | 75.10 | 220 / 504 |
spleen | 100% | 691.50 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 91% | 141.51 | 41 / 45 |
adrenal gland | 85% | 127.97 | 220 / 258 | 1% | 0.28 | 2 / 230 |
ovary | 17% | 19.77 | 31 / 180 | 68% | 40.60 | 292 / 430 |
prostate | 85% | 176.67 | 208 / 245 | 0% | 0 | 0 / 502 |
pancreas | 13% | 22.68 | 43 / 328 | 70% | 101.59 | 125 / 178 |
skin | 80% | 280.02 | 1447 / 1809 | 0% | 0.16 | 2 / 472 |
thymus | 41% | 52.81 | 270 / 653 | 39% | 14.84 | 233 / 605 |
adipose | 73% | 165.03 | 883 / 1204 | 0% | 0 | 0 / 0 |
breast | 64% | 101.71 | 296 / 459 | 3% | 1.20 | 30 / 1118 |
uterus | 19% | 40.09 | 33 / 170 | 41% | 47.86 | 188 / 459 |
peripheral blood | 57% | 108.93 | 532 / 929 | 0% | 0 | 0 / 0 |
blood vessel | 52% | 88.79 | 698 / 1335 | 0% | 0 | 0 / 0 |
kidney | 39% | 88.82 | 35 / 89 | 1% | 0.53 | 9 / 901 |
brain | 33% | 79.06 | 867 / 2642 | 0% | 0 | 0 / 705 |
liver | 24% | 34.69 | 54 / 226 | 3% | 2.74 | 12 / 406 |
heart | 13% | 15.51 | 116 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 3% | 0.88 | 1 / 29 |
muscle | 0% | 0.34 | 3 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006805 | Biological process | xenobiotic metabolic process |
GO_0006690 | Biological process | icosanoid metabolic process |
GO_0042573 | Biological process | retinoic acid metabolic process |
GO_1903604 | Biological process | cytochrome metabolic process |
GO_0019373 | Biological process | epoxygenase P450 pathway |
GO_0006693 | Biological process | prostaglandin metabolic process |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0005737 | Cellular component | cytoplasm |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0016712 | Molecular function | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen |
GO_0004796 | Molecular function | thromboxane-A synthase activity |
GO_0036134 | Molecular function | 12-hydroxyheptadecatrienoic acid synthase activity |
GO_0004497 | Molecular function | monooxygenase activity |
GO_0005506 | Molecular function | iron ion binding |
GO_0008401 | Molecular function | retinoic acid 4-hydroxylase activity |
GO_0020037 | Molecular function | heme binding |
GO_0106256 | Molecular function | hydroperoxy icosatetraenoate dehydratase activity |
GO_0008392 | Molecular function | arachidonic acid epoxygenase activity |
GO_0016836 | Molecular function | hydro-lyase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | CYP2S1 |
Protein name | Cytochrome P450 2S1 (EC 1.14.14.-) (CYPIIS1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152) (Thromboxane-A synthase) (EC 5.3.99.5) Cytochrome P450 family 2 subfamily S member 1 |
Synonyms | UNQ891/PRO1906 |
Description | FUNCTION: A cytochrome P450 monooxygenase involved in the metabolism of retinoids and eicosanoids . In epidermis, may contribute to the oxidative metabolism of all-trans-retinoic acid. For this activity, uses molecular oxygen inserting one oxygen atom into a substrate, and reducing the second into a water molecule, with two electrons provided by NADPH via cytochrome P450 reductase (NADPH--hemoprotein reductase) . Additionally, displays peroxidase and isomerase activities toward various oxygenated eicosanoids such as prostaglandin H2 (PGH2) and hydroperoxyeicosatetraenoates (HPETEs) . Independently of cytochrome P450 reductase, NADPH, and O2, catalyzes the breakdown of PGH2 to hydroxyheptadecatrienoic acid (HHT) and malondialdehyde (MDA), which is known to act as a mediator of DNA damage . . |
Accessions | ENST00000600561.1 ENST00000310054.9 [Q96SQ9-1] ENST00000593890.1 M0R2G8 M0R152 M0R057 ENST00000595590.1 ENST00000593545.5 Q96SQ9 M0QYI2 M0QY51 ENST00000597754.1 |